Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.
Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.
AirPROM: can imaging and modelling take us beyond FEV1?
SessionChairs: S. Wagers (Maasmechelen, Belgium)
Aims: Technological advancements in imaging and modelling are opening up new avenues in the structural and functional characterisation of respiratory disease. Where does this leave FEV1? AirPROM is an FP-7 ICT Virtual Physiological Human project in which the ERS is a partner. Its aim is to build a multi-scale patient-specific model of the human lung that can be used to predict outcomes and reduce the hypothesis space of respiratory diseases. AirPROM is actively applying cutting-edge imaging and modelling techniques to clinical trial data. The objective of this session is to engage the presenters and the audience in a lively discussion about the potential for imaging and modelling to move us beyond the FEV1. The discussion will be framed around imaging and modelling examples from the AirPROM project against the backdrop of the indisputable value of FEV1 as the centrepiece of the GOLD criteria.
HERMES SYLLABUS LINKS
ADULT: D.1 Pulmonary function testing